Inotuzumab Ozogamacin
Information about Inotuzumab Ozogamacin
Inotuzumab Ozogamacin Uses
Inotuzumab Ozogamacin is used in the treatment of Acute lymphoblastic leukemia.
How Inotuzumab Ozogamacin works
Inotuzumab Ozogamacin contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL) in adults. targets CD22 antigen expressed on immature B-cell lymphocytes and blocks further growth of tumor cells. This medicine restores normal blood counts and helps achieve complete remission from the disease.
Common side effects of Inotuzumab Ozogamacin
Low blood platelets, Decreased white blood cell count (neutrophils), Infection, Anemia (low number of red blood cells), Decreased white blood cell count (lymphocytes), Fatigue, Hemorrhage, Fever, Nausea, Headache, Febrile neutropenia, Increased transaminase level in blood, Abdominal pain, Increased gamma-glutamyltransferase, Increased bilirubin in the blood
Expert advice for Inotuzumab Ozogamacin
- Your doctor may monitor your blood counts and liver before you start taking Inotuzumab Ozogamacin and regularly throughout your treatment.
- Males and females of reproductive potential should use effective contraception during the treatment and for at least five and eight months respectively after the last dose.
- Avoid breastfeeding during the treatment and for two months after the last dose.
- Inotuzumab Ozogamacin can make you feel dizzy for the first few days. Rise slowly if you have been sitting or lying down for a long time.
- After starting the treatment with Inotuzumab Ozogamacin, you may be at risk of infection; so, try to avoid crowds or people with colds, and report fever or any other signs of infection immediately to your doctor.